Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Small Bowel Lymphoma.

Renard A. Rawls1, Kenneth J. Vega, Bruce W. Trotman

  • 1UMDNJ-University Hospital, Room i-253, 150 Bergen Street, Newark, NJ 07103, USA. bwtrotman@pol.net

Current Treatment Options in Gastroenterology
|January 11, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Esophageal Disorders in the Older Adult.

Current treatment options in gastroenterology·2025
Same journal

Endobariatrics: a Still Underutilized Weight Loss Tool.

Current treatment options in gastroenterology·2023
Same journal

Management of Post Ablative Barrett's Esophagus: a Review of Current Practices and Look at Emerging Technologies.

Current treatment options in gastroenterology·2023
Same journal

Inflammatory Bowel Disease Therapy and Venous Thromboembolism.

Current treatment options in gastroenterology·2023
Same journal

Ileal Pouch-Anal Anastomosis in the Older Adult: a Review of Postoperative Outcomes and Pouchitis Treatment.

Current treatment options in gastroenterology·2023
Same journal

Celiac Disease in the Elderly.

Current treatment options in gastroenterology·2023
See all related articles

Treatment for small bowel lymphoma depends on histology and stage. Early-stage disease may be cured with surgery and radiation, while advanced stages require chemotherapy, with regimens tailored to specific non-Hodgkin

Area of Science:

  • Oncology
  • Gastroenterology
  • Hematology

Background:

  • Small bowel lymphoma management requires multidisciplinary expertise.
  • Histology and staging are critical determinants of treatment strategy.
  • Factors like age, tumor size, and involvement patterns influence therapeutic decisions.

Purpose of the Study:

  • To outline current treatment approaches for small bowel lymphoma based on disease stage and histology.
  • To discuss the role of surgery, radiotherapy, and chemotherapy in managing different stages of small bowel lymphoma.
  • To highlight specific chemotherapy regimens, including CHOP and fludarabine combinations, and the emerging role of rituximab.

Main Methods:

  • Review of established treatment protocols for small bowel lymphoma.

Related Experiment Videos

  • Analysis of treatment outcomes based on disease stage (IE, IIE, IIIE, IVE) and histological subtype.
  • Evaluation of chemotherapy regimens such as CHOP, fludarabine, and chemoimmunotherapy with rituximab.

    • Main Results:

    • Stage IE disease has a ~75% cure rate with resection and radiotherapy.
    • Stage IIE disease benefits from combined chemotherapy and radiation therapy.
    • Advanced stages (IIIE, IVE) are managed with chemotherapy, achieving 25-40% disease control.

    Conclusions:

    • Optimal treatment for small bowel lymphoma is histology and stage-dependent.
    • Chemotherapy regimens, including CHOP for diffuse large B-cell lymphoma and fludarabine for low-grade lymphomas, are crucial.
    • Rituximab shows promise, particularly in combination therapies, but requires further clinical evaluation.